MYOS CORP Enters Exclusive Agreement with Science Biotech to Distribute Fortetropin® Products in Australia and New Zealand
CEDAR KNOLLS, N.J., Dec. 21, 2020 /PRNewswire/ -- MYOS ("MYOS" or the "Company"), a research-based advanced nutrition company with divisions that address both Human Nutrition and Animal Health, announced today that it has entered into an agreement with Science Biotech to exclusively distribute its Fortetropin® products in Australia and New Zealand. Fortetropin is a proprietary advanced nutrition product developed and owned by MYOS that has been shown in multiple human and veterinary clinical studies to accelerate gains in muscle mass, improve mobility, and enhance recovery from injury.
"We are very pleased to announce our partnership with Science Biotech. In Science Biotech we found a partner that is incredibly passionate about our products. Due to its sporting culture and love of pets, Australia was identified as a key market for us, and we couldn't be happier with the fit we've found with Science Biotech," said MYOS CEO Joseph Mannello. "This is the latest in a series of international distribution partnerships that we've recently been able to establish as we continue to grow our business globally."
"Science Biotech is very excited to launch Fortetropin in the Australian/New Zealand market," said Science Biotech Director Alicia Prince. "We are proud to be associated with a company such as MYOS CORP, which places such high value on clinical research and patient trials to validate the efficacy of its products. We saw a vast difference in the scientific research behind Fortetropin compared to other health and fitness products– that make grand statements that are largely unsubstantiated– currently being sold in this space."
Science Biotech will introduce sports nutrition brand, YOLKED®, and canine brand MYOS Canine Muscle Formula®, into Australia and New Zealand– widely recognized as premier markets for sports supplements and pet products.
"Australia is well known as a high performing market for health and fitness products," said Prince. "Sport has always played a significant role in Australia's culture and we are identified as a nation of sports lovers. Science Biotech envisages that the introduction of Fortetropin into Australia through the YOLKED brand will be hugely popular in both the professional athlete arena as well as the recreational fitness space. We have already received expressions of interest from several large retailers who were aware of the product internationally and are now keen to sell it direct to consumers in the Australian/New Zealand market. Science Biotech has also begun the exploration of sponsorship with professional athletes to help bring consumer awareness to the YOLKED brand in this region."
In addition to their sports culture, Australians have one of the highest pet ownership percentages in the world with over 61% of the population owning a pet, the majority being dogs. Science Biotech plans to introduce MYOS Canine Muscle Formula to veterinarian practices and larger pet retailers throughout Australia.
About MYOS CORP
These statements have not been evaluated by the Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease.
View original content to download multimedia:http://www.prnewswire.com/news-releases/myos-corp-enters-exclusive-agreement-with-science-biotech-to-distribute-fortetropin-products-in-australia-and-new-zealand-301196366.html
SOURCE MYOS CORP